Bay City Capital LLC

Director, 10% owner at MDGL; Other at NVRO; 10% owner at Epizyme, Inc.

Sold, on record
$124M
Dollars the filings state
Form 4 sales
4
Latest Jun 11, 2018
Form 144 notices
0
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Epizyme, Inc.Plan not stated
    Aug 25, 2014 2014

    Sold 366,666 shares at $33.98 ($12.5M)

    Bay City Capital LLC, 10% owner

    Sold 11.5% of holdings ($108M position)2.8M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Epizyme, Inc.Plan not stated
    Aug 26, 2014 +1 day

    Sold 200,000 shares at $35.14 ($7M)

    Bay City Capital LLC, 10% owner

    Sold 6.6% of holdings ($106M position)2.8M shares leftFiling

  3. 3 Form 4 sale NVROUnusual
    Jun 8, 2015 +286 days

    Sold 491,835 shares at $47.94 ($23.6M)

    Bay City Capital LLC, Other

    Sold 93.1% of holdings ($25.3M position)36,403 shares leftFirst sale on recordFiling

  4. 4 Form 4 sale MDGLUnusual
    Jun 11, 2018 +1099 days

    Sold 280,000 shares at $287.46 ($80.5M)

    Bay City Capital LLC, Director, 10% owner

    Sold 71.2% of holdings ($113M position)113,472 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Bay City Capital LLC
Source
Jun 11, 2018Jun 12, 2018MDGLDirector, 10% ownerForm 4 sale280,000$80.5M71.2%UnusualSEC
Jun 8, 2015Jun 17, 2015NVROOtherForm 4 sale491,835$23.6M93.1%UnusualSEC
Aug 26, 2014Aug 28, 2014Epizyme, Inc.10% ownerForm 4 sale200,000$7M6.6%Plan not statedSEC
Aug 25, 2014Aug 25, 2014Epizyme, Inc.10% ownerForm 4 sale366,666$12.5M11.5%Plan not statedSEC